Back to Journals » International Journal of Nanomedicine » Volume 6

Evaluation of iron oxide nanoparticle biocompatibility

Authors Hanini A, Schmitt A, Kacem K, Chau F, Ammar S, Gavard J

Published 14 April 2011 Volume 2011:6 Pages 787—794

DOI https://doi.org/10.2147/IJN.S17574

Review by Single-blind

Peer reviewer comments 2

Amel Hanini1,2,3,4,5, Alain Schmitt2,3,4, Kamel Kacem5, François Chau1,2, Souad Ammar1,2, Julie Gavard2,3,4
1Interface Traitement, Organisation et Dynamique des Systèmes (ITODYS), Université Paris 7, Paris, France; 2CNRS, Paris, France; 3Inserm, Paris, France; 4Univ Paris Descartes, Paris, France; 5Universite de Carthage, Jarzouna, Tunisia

Abstract: Nanotechnology is an exciting field of investigation for the development of new treatments for many human diseases. However, it is necessary to assess the biocompatibility of nanoparticles in vitro and in vivo before considering clinical applications. Our characterization of polyol-produced maghemite γ-Fe2O3 nanoparticles showed high structural quality. The particles showed a homogeneous spherical size around 10 nm and could form aggregates depending on the dispersion conditions. Such nanoparticles were efficiently taken up in vitro by human endothelial cells, which represent the first biological barrier to nanoparticles in vivo. However, γ -Fe2O3 can cause cell death within 24 hours of exposure, most likely through oxidative stress. Further in vivo exploration suggests that although γ–Fe2O3 nanoparticles are rapidly cleared through the urine, they can lead to toxicity in the liver, kidneys and lungs, while the brain and heart remain unaffected. In conclusion, γ-Fe2O3 could exhibit harmful properties and therefore surface coating, cellular targeting, and local exposure should be considered before developing clinical applications.

Keywords: nanoparticles, polyol process, endothelial cell, cytotoxicity, clearance

 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Biocompatibility of magnetic Fe3O4 nanoparticles and their cytotoxic effect on MCF-7 cells

Chen DZ, Tang QS, Li XD, Zhou XJ, Zang J, Xue WQ, Xiang JY, Guo CQ

International Journal of Nanomedicine 2012, 7:4973-4982

Published Date: 14 September 2012

Writing 3D patterns of microvessels

Juodkazis S

International Journal of Nanomedicine 2012, 7:3701-3702

Published Date: 13 July 2012

Simple room-temperature preparation of high-yield large-area graphene oxide

Huang NM, Lim HN, Chia CH, Yarmo MA, Muhamad MR

International Journal of Nanomedicine 2011, 6:3443-3448

Published Date: 19 December 2011

Effect of dispersants of multi-walled carbon nanotubes on cellular uptake and biological responses

Haniu H, Saito N, Matsuda Y, Kim YA, Park KC, Tsukahara T, Usui Y, Aoki K, Shimizu M, Ogihara N, Hara K, Takanashi S, Okamoto M, Ishigaki N, Nakamura K, Kato H

International Journal of Nanomedicine 2011, 6:3295-3307

Published Date: 9 December 2011

Biocompatibility of Fe3O4@Au composite magnetic nanoparticles in vitro and in vivo

Li Y, Liu J, Zhong Y, Zhang J, Wang Z, Wang L, An Y, Lin M, Gao Z, Zhang D

International Journal of Nanomedicine 2011, 6:2805-2819

Published Date: 9 November 2011

Novel docetaxel-loaded nanoparticles based on PCL-Tween 80 copolymer for cancer treatment

Ma Y, Zheng Y, Zeng X, Jiang L, Cheng H, Liu R, Huang L, Mei L

International Journal of Nanomedicine 2011, 6:2679-2688

Published Date: 1 November 2011

Effect of magnetic Fe3O4 nanoparticles with 2-methoxyestradiol on the cell-cycle progression and apoptosis of myelodysplastic syndrome cells

Xia G, Chen B, Ding J, Gao C, Lu H, Shao Z, Gao F, Wang X

International Journal of Nanomedicine 2011, 6:1921-1927

Published Date: 8 September 2011

Multi-access drug delivery network and stability

Mitatha S, Moongfangklang N, Jalil MA, Suwanpayak N, Ali J, Yupapin PP

International Journal of Nanomedicine 2011, 6:1757-1764

Published Date: 23 August 2011